Role of endogenous opioid peptides in the infarct size-limiting effect of adaptation to chronic continuous hypoxia

Life Sciences

Volumn 93, Issue 9-11, 2013, Pages 373-379

  Maslov, Leonid N ^a   Naryzhnaia, Natalia V ^a   Tsibulnikov, Sergey Yu ^a   Kolar, Frantisek ^b   Zhang, Yi ^c   Wang, Hongxin ^d   Gusakova, Anna M ^a   Lishmanov, Yury B ^a  

^a CARDIOLOGY RESEARCH INSTITUTE   (Russian Federation)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^c HEBEI MEDICAL UNIVERSITY   (China)

^d JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cardioprotection Opioid peptides; Chronic hypoxia; Myocardial infarction; Opioid receptors

Indexed keywords

17 METHYLNALOXONE; ENDORPHIN; NALTREXONE; NALTRIBEN; NORBINALTORPHIMINE; OPIATE PEPTIDE; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORONARY REPERFUSION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HYPOXIA; MALE; NONHUMAN; RAT; REPERFUSION INJURY; WISTAR RAT;

CARDIOPROTECTION; CHRONIC HYPOXIA; MYOCARDIAL INFARCTION; OPIOID PEPTIDES; OPIOID RECEPTORS;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANOXIA; ARRHYTHMIAS, CARDIAC; BETA-ENDORPHIN; ENKEPHALIN, METHIONINE; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; RATS; RATS, WISTAR; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU;

ANIMALIA; RATTUS;

EID: 84883459014     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.07.018     Document Type: Article

References (83)

1. E.E. Abdelhamid, and A.E. Takemori Characteristics of μ and δ opioid binding sites in striatal slices of morphine-tolerant and -dependent mice Eur J Pharmacol 198 1991 157 163
2. K.A. Aitchison, G.F. Baxter, M.M. Awan, R.M. Smith, D.M. Yellon, and L.H. Opie Opposing effects on infarction of delta and kappa opioid receptor activation in the isolated rat heart: implications for ischemic preconditioning Basic Res Cardiol 95 2000 1 10
3. M.A. Ansonoff, T. Wen, and J.E. Pintar Kappa2 opioid receptor subtype binding requires the presence of the DOR-1 gene Front Biosci 2 2010 772 780
4. ATP channel J Mol Cell Cardiol 31 1999 1821 1831
5. P.J. Birch, A.G. Hayes, M.J. Sheehan, and M.B. Tyers Norbinaltorphimine: antagonist profile at κ opioid receptors Eur J Pharmacol 144 1987 405 408
6. C. Bolte, G. Newman, and J.J. Schultz Hypertensive state, independent of hypertrophy, exhibits an attenuated decrease in systolic function on cardiac κ-opioid receptor stimulation Am J Physiol Heart Circ Physiol 296 2009 H967 H975
7. D.I. Brissett, J.L. Whistler, and R.M. van Rijn Contribution of mu and delta opioid receptors to the pharmacological profile of kappa opioid receptor subtypes Eur J Pain 16 2012 327 337
8. J.R. Bunzow, G. Zhang, C. Bouvier, C. Saez, O.K. Ronnekleiv, and M.J. Kelly Characterization and distribution of a cloned rat mu-opioid receptor J Neurochem 64 1995 14 19
9. J.L. Caffrey, M.O. Boluyt, A. Younes, B.A. Barron, L. O'Neil, and M.T. Crow Aging, cardiac proenkephalin mRNA and enkephalin peptides in the Fisher 344 rat J Mol Cell Cardiol 26 1994 701 711
10. Ca channel as a trigger for the cardioprotection induced by kappa-opioid receptor stimulation - its relationship with protein kinase C Br J Pharmacol 145 2005 984 991
11. G.D. Dalton, C.E. Bass, C.G. Van Horn, and A.C. Howlett Signal transduction via cannabinoid receptors CNS Neurol Disord Drug Targets 8 2009 422 431
12. F.M. Décaillot, R. Rozenfeld, A. Gupta, and L.A. Devi Cell surface targeting of μ-δ opioid receptor heterodimers by RTP4 Proc Natl Acad Sci U S A 105 2008 16045 16050
13. B.N. Dhawan, F. Cesselin, R. Raghubir, T. Reisine, P.B. Bradley, and P.S. Portoghese International Union of Pharmacology. XII. Classification of opioid receptors Pharmacol Rev 48 1996 567 592
14. J.M. Downey, A.M. Davis, and M.V. Cohen Signaling pathways in ischemic preconditioning Heart Fail Rev 12 2007 181 188
15. M. Dumont, and S. Lemaire Increased content of immunoreactive Leu-enkephalin and alteration of δ-opioid receptor in hearts of spontaneously hypertensive rats Neurosci Lett 94 1988 114 118
16. N. Dzimiri Receptor crosstalk. Implications for cardiovascular function, disease and therapy Eur J Biochem 269 2002 4713 4730
17. J. Fichna, A. Janecka, J. Costentin, and J.C. Do Rego The endomorphin system and its evolving neurophysiological role Pharmacol Rev 59 2007 88 123
18. J. Fichna, R. Staniszewska, J. Poels, J. Vanden Broeck, and A. Janecka μ-Opioid receptor ligands lack receptor subtype selectivity in the aequorin luminescence-based calcium assay Chem Biol Drug Des 70 2007 247 253
19. L.J. Forman, and O. Bagasra Demonstration by in situ hybridization of the proopiomelanocortin gene in the rat heart Brain Res Bull 28 1992 441 445
20. I. Gomes, B.A. Jordan, A. Gupta, N. Trapaidze, V. Nagy, and L.A. Devi Heterodimerization of μ and δ opioid receptors: a role in opiate synergy J Neurosci 20 2000 RC110
21. G.J. Gross Role of opioids in acute and delayed preconditioning J Mol Cell Cardiol 35 2003 709 718
22. E.R. Gross, A.K. Hsu, and G.J. Gross Acute methadone treatment reduces myocardial infarct size via the δ-opioid receptor in rats during reperfusion Anesth Analg 109 2009 1395 1402
23. G.J. Gross, J.E. Baker, A. Hsu, H.E. Wu, J.R. Falck, and K. Nithipatikom Evidence for a role of opioids in epoxyeicosatrienoic acid-induced cardioprotection in rat hearts Am J Physiol Heart Circ Physiol 298 2010 H2201 H2207
24. G.J. Gross, A. Hsu, K. Nithipatikom, I. Bobrova, and E. Bissessar Eribis peptide 94 reduces infarct size in rat hearts via activation of centrally located μ opioid receptors J Cardiovasc Pharmacol 59 2012 194 197
25. H.T. Guo, R.H. Zhang, Y. Zhang, L.J. Zhang, J. Li, and Q.X. Shi Endogenous κ-opioid peptide mediates the cardioprotection induced by ischemic postconditioning J Cardiovasc Pharmacol 58 2011 207 215
26. K.K. Haack, M.R. Tougas, K.T. Jones, S.S. El-Dahr, H. Radhakrishna, and N.A. McCarty A novel bioassay for detecting GPCR heterodimerization: transactivation of beta 2 adrenergic receptor by bradykinin receptor J Biomol Screen 15 2010 251 260
27. B.P. Head, H.H. Patel, D.M. Roth, N.C. Lai, I.R. Niesman, and M.G. Farquhar G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes J Biol Chem 280 2005 31036 31044
28. ATP channels Am J Physiol Heart Circ Physiol 280 2001 H377 H383
29. J.H. Jaffe, and W.R. Martin Opioid analgesics and antagonists A.G. Gilman, T.W. Rall, A.S. Nies, P. Taylor, The pharmacological basis of therapeutics 1990 Pergamon Press New York 485 521
30. N. Kabli, N. Martin, T. Fan, T. Nguyen, A. Hasbi, and G. Balboni Agonists at the δ-opioid receptor modify the binding of μ-receptor agonists to the μ-δ receptor hetero-oligomer Br J Pharmacol 161 2010 1122 1136
31. J. Kamei, A. Saitoh, M. Ohsawa, T. Suzuki, M. Misawa, and H. Nagase Antinociceptive effects of the selective non-peptidic δ-opioid receptor agonist TAN-67 in diabetic mice Eur J Pharmacol 276 1995 131 135
32. L.O. Karlsson, N. Bergh, L. Li, E. Bissessar, I. Bobrova, and G.J. Gross Dose-dependent cardioprotection of enkephalin analogue Eribis peptide 94 and cardiac expression of opioid receptors in a porcine model of ischaemia and reperfusion Eur J Pharmacol 674 2012 378 383
33. J.H. Kim, K.J. Chun, Y.H. Park, J. Kim, J.S. Kim, and Y.H. Jang Morphine-induced postconditioning modulates mitochondrial permeability transition pore opening via delta-1 opioid receptors activation in isolated rat hearts Korean J Anesthesiol 61 2011 69 74
34. P.Y. Law, L.J. Erickson-Herbrandson, Q.Q. Zha, J. Solberg, J. Chu, and A. Sarre Heterodimerization of μ- and δ-opioid receptors occurs at the cell surface only and requires receptor-G protein interactions J Biol Chem 280 2005 11152 11164
35. Yu.B. Lishmanov, L.N. Maslov, and K. Rice Permeability of blood-brain barrier for the ligands of opioid receptors Exp Clin Pharmacol 65 2002 1 7 (in Russian)
36. Yu.B. Lishmanov, N.V. Naryzhnaia, L.N. Maslov, and G.J. Gross The opioidergic link of antiarrhythmic effect of adaptation to hypoxia on a model of ischemia and reperfusion in vivo Pathol Physiol Exp Ther 1 2003 19 21 (in Russian)
37. X. Liu, M. Kai, L. Jin, and R. Wang Computational study of the heterodimerization between μ and δ receptors J Comput Aided Mol Des 23 2009 321 332
38. D.T. Longhi-Balbinot, D.F. Martins, D. Lanznaster, M.D. Silva, V.A. Facundo, and A.R. Santos Further analyses of mechanisms underlying the antinociceptive effect of the triterpene 3β, 6β, 16β- trihydroxylup-20(29)-ene in mice Eur J Pharmacol 653 2011 32 40
39. A. Mansour, M.T. Hoversten, L.P. Taylor, S.J. Watson, and H. Akil The cloned μ, δ and κ receptors and their endogenous ligands: Evidence for two opioid peptide recognition cores Brain Res 700 1995 89 98
40. L.N. Maslov, A.Yu. Lishmanov, E.V. Budankova, D.L. Stakheev, N.V. Solenkova, and E.I. Barzakh Contribution of the endogenous opioid system to regulation of heart resistance to the arrhythmogenic effect of short-term ischemia and reperfusion Biol Bull 32 2005 375 380
41. 1- opioid receptor activation Exp Clin Pharmacol 68 2005 25 29 (in Russian)
42. ATP channels and the autonomic nervous system Life Sci 84 2009 657 663
43. L.N. Maslov, Yu.B. Lishmanov, P.R. Oeltgen, E.I. Barzakh, A.V. Krylatov, and N.V. Naryzhnaya Comparative analysis of the cardioprotective properties of opioid receptor agonists in a rat model of myocardial infarction Acad Emer Med 17 2010 1239 1246
44. J. McDonald, A.D. Leonard, A. Serrano-Gomez, S.P. Young, J. Swanevelder, and J.P. Thompson Assessment of nociceptin/orphanin FQ and μ-opioid receptor mRNA in the human right atrium Br J Anaesth 104 2010 698 704
45. F.Z. Meerson, E.E. Ustinova, and E.H. Orlova Prevention and elimination of heart arrhythmias by adaptation to intermittent high altitude hypoxia Clin Cardiol 10 1987 783 789
46. V.V. Menshikov, L.N. Delectorskaia, R.P. Zolotnitskaia, Z.M. Andreeva, A.S. Ankyrskaia, and I.S. Balakhovsky The laboratory methods of investigation in clinic: manual 1987 Meditsyna Moscow
47. 2 receptor in kidney cells J Pharmacol Exp Ther 318 2006 1033 1043
48. J. Neckar, F. Papousek, O. Novakova, B. Ostadal, and F. Kolar Cardioprotective effects of chronic hypoxia and ischaemic preconditioning are not additive Basic Res Cardiol 97 2002 161 167
49. J. Neckar, O. Szarszoi, J. Herget, B. Ostadal, and F. Kolar Cardioprotective effect of chronic hypoxia is blunted by concomitant hypercapnia Physiol Res 52 2003 171 175
50. J. Neckar, B. Ostadal, and F. Kolar Myocardial infarct size-limiting effect of chronic hypoxia persists for five weeks of normoxic recovery Physiol Res 53 2004 621 628
51. Ca channels Curr Pharm Des 2013 Apr 10 (in press, Epub ahead of print)
52. B. Ostadal, and F. Kolar Cardiac adaptation to chronic high-altitude hypoxia: beneficial and adverse effects Respir Physiol Neurobiol 158 2007 224 236
53. G.W. Pasternak, and Y.X. Pan Mix and match: heterodimers and opioid tolerance Neuron 69 2011 6 8
54. J.N. Peart, and G.J. Gross Adenosine and opioid receptor-mediated cardioprotection in the rat: evidence for cross-talk between receptors Am J Physiol Heart Circ Physiol 285 2003 H81 H89
55. J.N. Peart, E.R. Gross, and G.J. Gross Effect of exogenous κ-opioid receptor activation in rat model of myocardial infarction J Cardiovasc Pharmacol 43 2004 410 415
56. J.N. Peart, E.R. Gross, and G.J. Gross Opioid-induced preconditioning: recent advances and future perspectives Vasc Pharmacol 42 2005 211 218
57. J.N. Peart, E.R. Gross, M.E. Reichelt, A. Hsu, J.P. Headrick, and G.J. Gross Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts Basic Res Cardiol 103 2008 454 463
58. J.N. Peart, L.E. See Hoe, G.J. Gross, and J.P. Headrick Sustained ligand-activated preconditioning via δ-opioid receptors J Pharmacol Exp Ther 336 2011 274 281
59. i responses to κ-opioid receptor stimulation in the heart of chronically hypoxic rats Am J Physiol Cell Physiol 279 2000 C1483 C1494
60. A. Rediger, P. Tarnow, A. Bickenbach, M. Schaefer, H. Krude, and A. Gruters Heterodimerization of hypothalamic G-protein-coupled receptors involved in weight regulation Obes Facts 2 2009 80 86
61. G.C. Rossi, G.P. Brown, L. Leventhal, K. Yang, and G.W. Pasternak Novel receptor mechanisms for heroin and morphine-6β-glucuronide analgesia Neurosci Lett 216 1996 1 4
62. S. Sakurada, J.E. Zadina, A.J. Kastin, S. Katsuyama, T. Fujimura, and K. Murayama Differential involvement of μ-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception Eur J Pharmacol 372 1999 25 30
63. 2 discriminate different μ-opioid receptor mediated antinociception in mice Br J Pharmacol 137 2002 1143 1146
64. A. Samii, U. Bickel, U. Stroth, and W.M. Pardridge Blood-brain barrier transport of neuropeptides: analysis with a metabolically stable dermorphin analogue Am J Physiol Endocrinol Metab 267 1994 E124 E131
65. D.K. Sarkar, A. Sengupta, C. Zhang, N. Boyadjieva, and S. Murugan Opiate antagonist prevents μ- and δ-opiate receptor dimerization to facilitate ability of agonist to control ethanol-altered natural killer cell functions and mammary tumor growth J Biol Chem 287 2012 16734 16747
66. J.E. Schultz, A.K. Hsu, and G.J. Gross Ischemic preconditioning is mediated by a peripheral opioid receptor mechanism in the intact rat heart J Mol Cell Cardiol 29 1997 1355 1362
67. 1- but not μ- or κ-opioid receptors Circulation 97 1998 1282 1289
68. J. Shan, X.C. Yu, M.L. Fung, and T.M. Wong Attenuated "cross talk" between κ-opioid receptors and β-adrenoceptors in the heart of chronically hypoxic rats Pflugers Arch - Eur J Physiol 444 2002 126 132
69. 2 receptor gene is a target of angiotensin II type 1 receptor signaling J Am Soc Nephrol 18 2007 1140 1149
70. 1 opioid receptor antagonist in the mouse spinal cord Life Sci 52 1993 769 775
71. J.W. Taylor, and E.T. Kaiser Opioid receptor selectivity of peptide models of β-endorphin Int J Pept Protein Res 34 1989 75 80
72. G. Tong, Z. Sun, X. Wei, C. Gu, A.D. Kaye, and Y. Wang U50,488H postconditioning reduces apoptosis after myocardial ischemia and reperfusion Life Sci 88 2011 31 38
73. S. Van Dorpe, A. Adriaens, I. Polis, K. Peremans, J. Van Bocxlaer, and B. De Spiegeleer Analytical characterization and comparison of the blood-brain barrier permeability of eight opioid peptides Peptides 31 2010 1390 1399
74. C. Ventura, L. Bastagli, P. Bernardi, C.M. Caldarera, and C. Guarnieri Opioid receptors in rat cardiac sarcolemma: effect of phenylephrine and isoproterenol Biochim Biophys Acta 987 1989 69 74
75. G.Y. Wang, S. Wu, J.M. Pei, X.C. Yu, and T.M. Wong κ- but not δ-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats Am J Physiol Heart Circ Physiol 280 2001 H384 H391
76. J. Weil, O. Zolk, J. Griepentrog, U. Wenzel, W.H. Zimmermann, and T. Eschenhagen Alterations of the preproenkephalin system in cardiac hypertrophy and its role in atrioventricular conduction Cardiovasc Res 69 2006 412 422
77. G.T.C. Wong, Y. Lu, B. Mei, Z. Xia, and M.G. Irwin Cardioprotection from remote preconditioning involves spinal opioid receptor activation Life Sci 91 2012 860 865
78. L. Yao, K. McFarland, P. Fan, Z. Jiang, T. Ueda, and I. Diamond Adenosine A2a blockade prevents synergy between μ-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats Proc Natl Acad Sci U S A 103 2006 7877 7882
79. A.S. Yekkirala, M.L. Banks, M.M. Lunzer, S.S. Negus, K.C. Rice, and P.S. Portoghese Clinically employed opioid analgesics produce antinociception via μ-δ opioid receptor heteromers in Rhesus monkeys ACS Chem Neurosci 3 2012 720 727
80. D.M. Yellon, and J.M. Downey Preconditioning the myocardium: from cellular physiology to clinical cardiology Physiol Rev 83 2003 1113 1151
81. A.J. Zatta, H. Kin, D. Yoshishige, R. Jiang, N. Wang, and J.G. Reeves Evidence that cardioprotection by postconditioning involves preservation of myocardial opioid content and selective opioid receptor activation Am J Physiol Heart Circ Physiol 294 2008 H1444 H1451
82. Y. Zhang, M.G. Irwin, T.M. Wong, M. Chen, and C.M. Cao Ramifentanil preconditioning confers cardioprotection via cardiac κ- and δ-opioid receptors Anesthesiology 102 2005 371 388
83. R. Zimlichman, D. Gefel, H. Eliahou, Z. Matas, B. Rosen, and S. Gass Expression of opioid receptors during heart ontogeny in normotensive and hypertensive rats Circulation 93 1996 1020 1025